“Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s188. doi:10.25251/skin.7.supp.188.